Optimized pathway to schistosomiasis elimination in China: a scrutiny using a marginal benefit approach
10.16250/j.32.1374.2023016
- VernacularTitle:以边际效益视角审视中国消除血吸虫病的优化路径
- Author:
Qin LI
1
;
Guojing YANG
2
;
Jinxin ZHENG
3
;
Jing XU
1
;
Xiaonong ZHOU
1
,
4
Author Information
1. National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention (Chinese Center for Tropical Diseases Research), National Health Commission Key Laboratory of Parasite and Vector Biology, WHO Collaborating Centre for Tropical Diseases, National Center for International Research on Tropical Diseases, Shanghai 200025, China
2. School of Tropical Medicine, Hainan Medical University, China
3. Ruijin Hospital Affiliated to The Shanghai Jiao Tong University Medical School, China
4. School of Global Health, Chinese Center for Tropical Diseases Research and Shanghai Jiao Tong University School of Medicine, One Health Center, Shanghai Jiao Tong University and The Edinburgh University, Shanghai 200025, China
- Publication Type:Journal Article
- Keywords:
Schistosomiasis;
Marginal benefit;
Elimination pathway;
Optimized strategy;
Economic evaluation
- From:
Chinese Journal of Schistosomiasis Control
2023;35(1):1-6
- CountryChina
- Language:Chinese
-
Abstract:
Following concerted efforts for over 7 decades, great achievements have been gained in the national schistosomiasis control program of China. Currently, China is moving towards the stage of schistosomiasis elimination, when the major task is to make full use of available resources to improve schistosomiasis surveillance and response to sustainably consolidate gained schistosomiasis control achievements and prevent re-emerging schistosomiasis. There is therefore an urgent need for optimization of interventions for schistosomiasis elimination. Based on analysis of socioeconomic features at different stages of the national schistosomiasis control program in China, this review discusses the relationship between the needs of assessment of schistosomiasis elimination interventions and the optimized strategy of schistosomiasis elimination at different stages of the national schistosomiasis control program using a marginal benefit approach and proposes the optimized schistosomiasis elimination strategy that allows the highest marginal benefit with currently available schistosomiasis elimination costs, so as to provide the optimal strategic pathway to schistosomiasis elimination and facilitate the achievement of the targets set in Healthy China 2030.
